U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07808671) titled 'A Decision Support Tool for Pancreatic Cancer Screening -Aim 2' on Aug. 25.
Brief Summary: Pancreatic cancer has a rising incidence and poor survival. Early detection in high-risk individuals may substantially improve outcomes. Although guidelines recommend screening for individuals with hereditary cancer syndromes or certain genetic variants, pancreatic cancer screening remains uncertain due to limited evidence of mortality benefit, unclear screening strategies, potential harms, resource requirements, and low adherence. Shared decision-making between patients and providers is therefore essential, but no decision aid currently exis...